GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 2 filers reported holding GENMAB A/S in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $535,998 | -17.1% | 15,197 | -10.6% | 0.02% | -20.0% |
| Q2 2023 | $646,246 | +7.5% | 17,002 | +6.8% | 0.02% | -4.8% |
| Q1 2023 | $600,913 | -9.0% | 15,914 | +2.2% | 0.02% | -22.2% |
| Q4 2022 | $660,111 | +46.0% | 15,576 | +10.8% | 0.03% | +35.0% |
| Q3 2022 | $452,000 | +54.8% | 14,060 | +56.4% | 0.02% | +42.9% |
| Q2 2022 | $292,000 | +1.4% | 8,988 | +12.8% | 0.01% | 0.0% |
| Q1 2022 | $288,000 | +34.6% | 7,969 | +47.4% | 0.01% | +7.7% |
| Q4 2021 | $214,000 | -8.5% | 5,407 | +0.9% | 0.01% | -38.1% |
| Q3 2021 | $234,000 | +4.5% | 5,361 | -21.6% | 0.02% | -38.2% |
| Q1 2021 | $224,000 | -36.4% | 6,836 | -20.9% | 0.03% | -55.8% |
| Q4 2020 | $352,000 | +12.8% | 8,645 | +1.6% | 0.08% | -12.5% |
| Q3 2020 | $312,000 | +38.1% | 8,511 | +27.7% | 0.09% | -14.6% |
| Q2 2020 | $226,000 | – | 6,667 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $10,291,898 | 3.87% |
| Arlington Capital Management, Inc. | 26,115 | $1,106,754 | 1.24% |
| Dorsey Wright & Associates | 87,451 | $3,706,173 | 1.08% |
| Hardman Johnston Global Advisors LLC | 604,982 | $25,639,137 | 1.00% |
| TORRAY INVESTMENT PARTNERS LLC | 128,564 | $5,448,542 | 0.98% |
| Yorktown Management & Research Co Inc | 16,600 | $703,508 | 0.86% |
| First Light Asset Management, LLC | 160,263 | $6,791,946 | 0.63% |
| KLR INVESTMENT ADVISORS, LLC | 12,604 | $534,158 | 0.44% |
| Campbell & CO Investment Adviser LLC | 42,851 | $1,816,025 | 0.43% |
| Integrated Investment Consultants, LLC | 15,946 | $675,791 | 0.23% |